PIL against Covaxin trial on 2-18 age group: HC seeks Centre’s stand
New Delhi: A PIL to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech ...
Read moreDetailsNew Delhi: A PIL to set aside the permission granted by the Drugs Controller General of India to Bharat Biotech ...
Read moreDetailsNew Delhi: After the alleged death of a volunteer enrolled in Bharat Biotech's Covaxin clinical trial in Bhopal, the Hyderabad-based ...
Read moreDetails
Over the decades, since Independence, India’s southern states have achieved great success in population control with their governments aggressively promoting...
Read moreDetailsBy Aakar Patel Nowadays for a homeless person to fulfi ll the requirement of a place of residence, ‘The BLO...
Read moreDetailsBy Dilip Cherian India’s latest babu reshuffle story is not really about transfers or appointments. It is about a deeper...
Read moreDetailsFinally, the much-awaited meeting between US President Donald Trump and his Chinese counterpart Xi Jinping is taking place. Trump’s three-day...
Read moreDetails
